Inventor
CALIAS PERICLES
US29 patents
⚠️ This page may combine multiple inventors who share the name “CALIAS PERICLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIRE HUMAN GENETIC THERAPIES
9 patentsUS9814764B2Nov 14, 2017
Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidase
SHIRE HUMAN GENETIC THERAPIES9 citations90
US9220677B2Dec 29, 2015
Methods and compositions for CNS delivery of iduronate-2-sulfatase
SHIRE HUMAN GENETIC THERAPIES16 citations90
US11260112B2Mar 1, 2022
Methods and compositions for CNS delivery of iduronate-2-sulfatase
SHIRE HUMAN GENETIC THERAPIES2 citations83
US10456454B2Oct 29, 2019
CNS delivery of therapeutic agents
SHIRE HUMAN GENETIC THERAPIES6 citations83
US11065308B2Jul 20, 2021
Methods and compositions for CNS delivery of heparan n-sulfatase
SHIRE HUMAN GENETIC THERAPIES6 citations82
US11065307B2Jul 20, 2021
Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety
SHIRE HUMAN GENETIC THERAPIES2 citations81
US11471516B2Oct 18, 2022
CNS delivery of therapeutic agents
SHIRE HUMAN GENETIC THERAPIES1 citations72
US10660944B2May 26, 2020
Stable formulations for CNS delivery of arylsulfatase A
SHIRE HUMAN GENETIC THERAPIES5 citations68
US10646554B2May 12, 2020
Methods and compositions for CNS delivery of arylsulfatase A
SHIRE HUMAN GENETIC THERAPIES0 citations60
GENZYME CORP
6 patentsUS6521223B1Feb 18, 2003
Single phase gels for the prevention of adhesions
GENZYME CORP206 citations99
US6610669B1Aug 26, 2003
Water insoluble derivatives of polyanionic polysaccharides
GENZYME CORP53 citations96
US6749865B2Jun 15, 2004
Modification of biopolymers for improved drug delivery
GENZYME CORP26 citations92
US7189413B2Mar 13, 2007
Drug delivery of proteins from polymeric blends
GENZYME CORP11 citations84
US7417021B2Aug 26, 2008
Biologically active conjugate of a biopolymer and therapeutic agent
GENZYME CORP5 citations74
US7456220B2Nov 25, 2008
Immunodulatory compositions and methods of use thereof
GENZYME CORP2 citations62
TAKEDA PHARMACEUTICALS CO
4 patentsUS12409210B2Sep 9, 2025
CNS delivery of therapeutic agents
TAKEDA PHARMACEUTICALS CO0 citations72
US12121569B2Oct 22, 2024
Methods and compositions for CNS delivery of iduronate-2-sulfatase
TAKEDA PHARMACEUTICALS CO0 citations72
US12161702B2Dec 10, 2024
Methods and compositions for CNS delivery of heparan N-sulfatase
TAKEDA PHARMACEUTICALS CO0 citations71
US12168041B2Dec 17, 2024
Methods and compositions for CNS delivery of arylsulfatase A
TAKEDA PHARMACEUTICALS CO0 citations60